Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: Bioeng Transl Med. 2017 Feb 3;2(1):120–130. doi: 10.1002/btm2.10052

Figure 3.

Figure 3

Anti-OVA IgG titers were assessed two weeks after priming (3A) and boosting (3B) immunizations. Each data point represents the serum dilution factor past which antibody levels were indistinguishable from those in serum of PBS-immunized mice (G6). Each data point is the average titer of two technical replicates, and titers were assessed for each of the 5 mice per group. (* = p < 0.05)